BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2018
View Archived Issues
miRNA551b found as therapeutic target for AML
Read More
ITI-333 shows promise for the treatment of pain and substance abuse-derived disorders
Read More
Scripps Research Institute presents mu-opioid receptor ligand SR-17018
Read More
CSIC Zika virus vaccine shows promise in mouse infection models
Read More
Ionis begins phase I/II study of ION-TTR-LRx in healthy subjects and patients with hATTR
Read More
New tumor organoid includes microenvironment
Read More
Responses seen with blinatumomab monotherapy in relapsed/refractory B-cell non-Hodgkin's lymphoma
Read More
Rivaroxaban thromboprophylaxis effective only during treatment period in cancer patients
Read More
Quinazoline can serve as a novel core structure in the design of potent BRD4 inhibitors
Read More
ASLAN Pharmaceuticals presents phase II data for ASLAN-003 in AML patients
Read More
Geranylgeranyl diphosphate synthase inhibitors RAM-2061, RAM-2093 show promise for multiple myeloma
Read More
Aimmune Therapeutics submits IND application for AR-201 as treatment of egg allergy
Read More
Combination approach revs up beta cell production
Read More
Platform could prove broad strategy against emerging viruses
Read More
MUC17 and PCNX1 as novel biomarkers of chemotherapy response in breast cancer
Read More
Elzonris receives FDA approval for the treatment of blastic plasmacytoid dendritic cell neoplasm
Read More
Novartis receives approval in the E.U. for expanded indication for Kisqali
Read More
Suglat Tablets approved for additional indication of type 1 diabetes mellitus in Japan
Read More
FDA approves Inbrija
Read More
FDA grants early approval for Ultomiris for the treatment of adults with PNH
Read More
Merck KGaA and Pfizer terminate JAVELIN Ovarian 100 study of avelumab
Read More
Phase II TRAXAR study does not meet primary endpoint
Read More
Life Science Institute initiates exploratory clinical trial of CL-2020 in epidermolysis bullosa
Read More
Novartis reports compounds for treatment of parasitic diseases
Read More
Esteve Pharmaceuticals patent reports agents for the treatment of pain
Read More
Hemlibra subcutaneous injection approved in Japan for hemophilia A without inhibitors
Read More
Chugai receives approval in Japan for Tecentriq for additional dosing in NSCLC
Read More
FDA approves IND for anti-GM-CSF monoclonal antibody TJM2
Read More